As of May 25
| +0.39 / +2.18%|
The 14 analysts offering 12-month price forecasts for Amneal Pharmaceuticals Inc have a median target of 19.00, with a high estimate of 35.00 and a low estimate of 16.00. The median estimate represents a +3.88% increase from the last price of 18.29.
The current consensus among 16 polled investment analysts is to Hold stock in Amneal Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.